비교리스트

 카트 문의
시장보고서
상품코드
1565707

세계의 체외 전사 템플릿 시장 : 제품별, 용도별, 질병 유형별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

In-vitro Transcription Templates Market, By Product, By Application, By Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 269 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

세계 체외 전사 템플릿 시장 규모는 2023년 2억 5,143만 달러로 2024-2032년 연평균 21.09% 성장할 것으로 예상됩니다.

체외 전사 템플릿 시장 - 시장 역학

RNA 기반 치료제 및 백신에 대한 수요 확대, 생명공학 연구 증가도 시장 수요를 촉진할 것으로 예상

소분자 간섭 RNA(siRNA)와 안티센스 올리고뉴클레오티드(ASO)를 포함한 RNA 기반 치료제의 개발로 고품질 RNA 생산에 대한 수요가 증가하고 있습니다. 화이자 바이오텍과 Moderna와 같은 COVID-19용 mRNA 백신은 체외 전사(In-vitro transcription, IVT) 템플릿에 대한 관심을 크게 증가시켰으며, 체외 전사는 mRNA 백신의 신속한 설계 및 생산이 가능하기 때문에 의약품 개발에서 매우 중요한 역할을 하고 있습니다. CRISPR-Cas9와 같은 유전자 편집 도구의 등장으로 체외 전사는 유전체 편집에 필수적인 가이드 RNA(gRNA) 생성에 활용되고 있습니다.

맞춤형 의료가 발전함에 따라 암 면역치료와 같은 맞춤형 치료를 위한 맞춤형 RNA를 생산할 수 있는 능력은 효율적인 IVT 템플릿 기술에 대한 수요를 촉진하고 있습니다. 바이오센서, 생명공학 응용 및 새로운 생물학적 회로를 위한 RNA를 효율적으로 생산해야 하는 필요성이 전사 템플릿에 대한 수요를 지속적으로 뒷받침하고 있습니다. 또한, 제약 및 생명공학 산업은 연구개발에 많은 투자를 하고 있으며, 이는 전사 템플릿에 대한 수요를 뒷받침하고 있습니다. 과학자들은 유전자 발현, 단백질 합성 및 세포 메커니즘을 연구하기 위해 체외 전사 템플릿을 사용하고 있습니다.

체외 전사 템플릿 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 21.09%의 CAGR로 매년 성장할 것으로 예상됩니다.

제품별로는 DNA 템플릿 부문이 전사를 촉진하는 높은 효율성으로 인해 2023년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

용도별로는 COVID-19 및 기타 바이러스 감염증의 확산으로 인해 백신 부문이 2023년 주요 응용 분야로 부상했습니다.

질병 유형별로는 폐암, 백혈병, 유방암 등의 유행으로 2023년에는 암 분야가 주요 질병 유형으로 부상했습니다.

지역별로는 2023년 북미가 주요 수익원이었습니다. 이는 연구개발과 신약개발에 대한 정부의 지원 덕분입니다.

체외 전사 템플릿 시장 - 세분화 분석:

체외 전사 템플릿 세계 시장은 제품, 응용 분야, 질병 유형 및 지역에 따라 세분화됩니다.

시장은 제품별로 DNA 템플릿, RNA 템플릿, 템플릿 및 전사 키트, 기타 등 4가지 범주로 나뉘며, DNA 템플릿 부문이 시장을 주도하고 있습니다. DNA 템플릿은 높은 효율성과 시퀀싱 및 전사 과정에서 견고한 특성을 가지고 있어 시장 성장에 기여하고 있습니다.

시장은 용도별로 백신과 치료제 두 가지로 나뉩니다. 백신 부문이 시장을 지배하고 있습니다. 백신은 주로 바이러스 감염을 표적으로 삼는 데 사용되며 다른 유형보다 더 효과적이기 때문에 시장 성장을 주도하고 있습니다.

질병 유형별로는 암, 감염성 질환, 유전성 질환, 생활습관병, 기타 5가지 범주로 분류됩니다. 암 부문은 시장을 독점하고 있으며, 예측 기간 동안 높은 우위를 유지할 것으로 예상됩니다. 폐암, 유방암, 백혈병의 유병률 증가가 이 부문의 성장을 보완하고 있습니다.

체외 전사 템플릿 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 북미는 세계 시장에서 가장 큰 매출 점유율을 차지하고 있습니다. 미국은 특히 RNA 기반 치료제 및 백신 개발에서 확고한 생명공학 및 제약 부문을 보유하고 있어 세계 시장을 장악하고 있습니다. 아시아태평양에서는 중국이 생명공학 분야의 성장, RNA 기반 치료제에 대한 투자 증가, 생명공학 연구개발에 대한 정부 지원으로 인해 IVT 템플릿 시장의 주요 지역으로 빠르게 부상하고 있습니다. 헬스케어 혁신에 대한 정부의 집중과 세계 제약사와의 파트너십이 시장을 주도하고 있습니다.

체외 전사 템플릿 시장 - 경쟁 상황:

체외 전사(IVT) 템플릿 시장은 생명공학 및 제약 업계의 주요 기업들이 RNA 기반 기술 혁신에 집중하면서 경쟁이 치열해지고 있습니다. 이들 기업은 RNA 생산을 위한 고품질 전사 템플릿 개발에 투자하여 mRNA 백신, RNA 기반 치료제, 유전자 편집 등의 분야에서 진전을 이루기 위해 노력하고 있습니다. TriLink, Aldevron, Merck 등 주요 기업들은 제약회사와 제휴하여 RNA 기반 백신 및 치료제 생산에 필수적인 IVT 구성요소를 공급하고 있으며, TriLink, Aldevron, Merck 등은 mRNA 백신 및 RNA 기반 의약품에 대한 수요 증가에 대응하기 위해 특히 고품질 RNA 생산을 위한 제조 능력 확대에 많은 투자를 하고 있습니다.

2023년 9월, 머크는 mRNA의 개발, 제조, 상업화 및 제품 테스트의 완전 통합 서비스를 제공하는 최초의 CTDMO가 되었습니다.

2023년 의학연구위원회(MRC)와 생명공학 및 생물과학연구위원회(BBSRC) 등 영국 연구위원회는 RNA 생물학 및 유전체학 기초 연구와 응용 연구에 많은 자금을 배정했습니다.

목차

제1장 체외 전사 템플릿 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 체외 전사 템플릿의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 체외 전사 템플릿 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 체외 전사 템플릿 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 체외 전사 템플릿 시장 상황

  • 체외 전사 템플릿 시장 점유율 분석 : 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 체외 전사 템플릿 시장 - 제품별

  • 개요
    • 제품별 부문 점유율 분석
    • DNA 템플릿
    • RNA 템플릿
    • 템플릿과 전사 키트
    • 기타

제8장 체외 전사 템플릿 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 백신
    • 치료제

제9장 체외 전사 템플릿 시장 - 질환 유형별

  • 개요
    • 질병 유형별 부문 점유율 분석
    • 암
    • 감염증
    • 유전성 질환
    • 생활습관병
    • 기타

제10장 체외 전사 템플릿 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 체외 전사 템플릿 업계

  • 경쟁 대시보드
  • 기업 개요
    • Thermo Fisher Scientific
    • Merck KGaA
    • Promega Corporation
    • Agilent Technologies
    • New England Biolabs
    • Takara Bio Inc.
    • Synthego Corporation
    • TriLink BioTechnologies
    • Aldevron
    • Bio-Rad Laboratories
    • GenScript Biotech Corporation
    • Sigma-Aldrich
    • CellScript
    • QIAGEN NV
    • Lucigen Corporation
    • 기타

제12장 애널리스트의 전방위 전망

ksm 24.10.28

REPORT HIGHLIGHT

In-vitro Transcription Templates Market size was valued at USD 251.43 Million in 2023, expanding at a CAGR of 21.09% from 2024 to 2032.

In-vitro transcription templates are DNA sequences used to synthesize RNA in a controlled laboratory setting outside of a living organism. These templates serve as the blueprints for RNA synthesis and are essential in experiments where researchers want to produce specific RNA molecules.

In-vitro Transcription Templates Market- Market Dynamics

Growing demand from RNA-based therapeutics & vaccines and increasing research in biotech is also expected to propel market demand

The development of RNA-based therapeutics, including small interfering RNA (siRNA) and antisense oligonucleotides (ASOs), has increased demand for high-quality RNA production. mRNA vaccines, like those developed for COVID-19 disease like Pfizer-BioNTech and Moderna, have significantly boosted interest in in-vitro transcription (IVT) templates. The ability to rapidly design and produce mRNA vaccines has made in-vitro transcription crucial in pharmaceutical development. The rise of gene-editing tools like CRISPR-Cas9 uses in-vitro transcription to generate guide RNA (gRNA), which is critical for genome editing applications.

As personalized medicine evolves, the ability to produce tailor-made RNA for individualized treatments like cancer immunotherapies drives the demand for efficient IVT template technology. The need for efficient production of RNA for biosensors, bioengineering applications, and novel biological circuits continues to support the demand for transcription templates. In addition, the pharmaceutical and biotechnology industries are investing heavily in R&D, which supports the demand for transcription templates. Scientists use in-vitro transcription templates to study gene expression, protein synthesis, and cellular mechanisms.

In-vitro Transcription Templates Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.09% over the forecast period (2024-2032)

Based on Product segmentation, the DNA templates segment was predicted to show maximum market share in the year 2023, owing to their higher efficiency in driving transcription.

Based on Application segmentation, vaccines segment was the leading Application segment in 2023, due to the growing prevalence of COVID-19 and other viral infections.

Based on Disease Type segmentation, cancer segment was the leading Disease Type segment in 2023, due to prevalence of lung cancer, leukemia, breast cancer, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the government support in research & new drugs development.

In-vitro Transcription Templates Market- Segmentation Analysis:

The Global In-vitro Transcription Templates Market is segmented on the basis of Product, Application, Disease Type, and Region.

The market is divided into four categories based on Product: DNA templates, RNA templates, templates & transcription kits, and others. The DNA templates segment dominates the market. DNA templates offer high efficiency & are robust in sequencing & transcription process which is contributing to market growth.

The market is divided into two categories based on Application: vaccines and therapeutics. The vaccines segment dominates the market. The vaccines are mainly used in targeting viral infections and are more effective than other type boosting market growth.

The market is divided into five categories based on Disease Type: cancer, infectious diseases, genetic diseases lifestyle diseases, and others. The cancer segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing prevalence of lung, breast cancer, leukemia are supplementing segment growth.

In-vitro Transcription Templates Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America held the largest revenue share in the global market. The U.S. dominates the global market due to its well-established biotechnology and pharmaceutical sectors, particularly in the development of RNA-based therapies and vaccines. In Asia Pacific, China is rapidly emerging as a key player in the IVT template market due to its growing biotech sector, increasing investments in RNA-based therapeutics, and government support for biotechnology R&D. Increased government focus on healthcare innovation and collaborations with global pharma companies are driving the market.

In-vitro Transcription Templates Market- Competitive Landscape:

The In-vitro Transcription (IVT) Templates market is significantly competitive, with several key players across the biotechnology and pharmaceutical industries focusing on innovations in RNA-based technologies. These companies are investing in developing high-quality transcription templates for RNA production, enabling advancements in areas like mRNA vaccines, RNA-based therapeutics, and gene editing. Key players are forming alliances with pharmaceutical companies to supply critical IVT components for the production of RNA-based vaccines and therapeutics. Companies like TriLink, Aldevron, and Merck are heavily investing in expanding their manufacturing capabilities, particularly for high-quality RNA production, to meet the growing demand for mRNA vaccines and RNA-based drugs.

In September 2023, Merck became the first CTDMO to offer fully integrated services for mRNA development, manufacturing, commercialization, and product testing.

In 2023, UK research councils such as the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC) allocated substantial funding for basic and applied research in RNA biology, genomics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Merck KGaA
  • Promega Corporation
  • Agilent Technologies
  • New England Biolabs
  • Takara Bio Inc.
  • Synthego Corporation
  • TriLink BioTechnologies
  • Aldevron
  • Bio-Rad Laboratories
  • GenScript Biotech Corporation
  • Sigma-Aldrich
  • CellScript
  • QIAGEN N.V.
  • Lucigen Corporation
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • DNA templates
  • RNA templates
  • Templates & Transcription Kits
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Vaccines
  • Therapeutics

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Cancer
  • Infectious diseases
  • Genetic diseases lifestyle diseases
  • Others

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. In-vitro Transcription Templates Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. In-vitro Transcription Templates Market Snippet by Product
    • 2.1.2. In-vitro Transcription Templates Market Snippet by Application
    • 2.1.3. In-vitro Transcription Templates Market Snippet by Disease Type
    • 2.1.4. In-vitro Transcription Templates Market Snippet by Country
    • 2.1.5. In-vitro Transcription Templates Market Snippet by Region
  • 2.2. Competitive Insights

3. In-vitro Transcription Templates Key Market Trends

  • 3.1. In-vitro Transcription Templates Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. In-vitro Transcription Templates Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. In-vitro Transcription Templates Market Opportunities
  • 3.4. In-vitro Transcription Templates Market Future Trends

4. In-vitro Transcription Templates Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. In-vitro Transcription Templates Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. In-vitro Transcription Templates Market Landscape

  • 6.1. In-vitro Transcription Templates Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. In-vitro Transcription Templates Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. DNA templates
    • 7.1.3. RNA templates
    • 7.1.4. Templates & Transcription Kits
    • 7.1.5. Others

8. In-vitro Transcription Templates Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Vaccines
    • 8.1.3. Therapeutics

9. In-vitro Transcription Templates Market - By Disease Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 9.1.2. Cancer
    • 9.1.3. Infectious diseases
    • 9.1.4. Genetic diseases lifestyle diseases
    • 9.1.5. Others

10. In-vitro Transcription Templates Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. In-vitro Transcription Templates Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. In-vitro Transcription Templates Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. In-vitro Transcription Templates Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. In-vitro Transcription Templates Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. In-vitro Transcription Templates Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- In-vitro Transcription Templates Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Merck KGaA
    • 11.2.3. Promega Corporation
    • 11.2.4. Agilent Technologies
    • 11.2.5. New England Biolabs
    • 11.2.6. Takara Bio Inc.
    • 11.2.7. Synthego Corporation
    • 11.2.8. TriLink BioTechnologies
    • 11.2.9. Aldevron
    • 11.2.10. Bio-Rad Laboratories
    • 11.2.11. GenScript Biotech Corporation
    • 11.2.12. Sigma-Aldrich
    • 11.2.13. CellScript
    • 11.2.14. QIAGEN N.V.
    • 11.2.15. Lucigen Corporation
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제